REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary
Home > Formulary : Adult > Recent Decisions > 2019 >

Decisions 23rd July 2019

At the meeting on the 23rd July the following decisions were agreed:

New Drug Requests

Approved

Methylphenidate IR Formulation (Amber SCP)

Shared Care Protocol/ TLS Change in status

Ranolazine (Amber SCP)

  • Updated SCP

Further work needed

Utrogestan 

  • Further work is needed to clarify whether this will be placed in the local HRT pathway after first line oral therapies

Cinacalcet

  • Further work is needed in regards to the evidence for monitoring arrangements for patients with complex primary hyperparathyroidism in adults

Dexamfetamine

  • Change from TLS Red to TLS Amber 3 months for ADHD pending shared care protocol